GlassScriptPhysician profile
Ryan D Melchior
NPI 1316267511
$53,955.84
in general payments reported to CMS, 2019-2025
55 companies · $9,868 in 2025
The $9,868 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $6,828 · 2021: $1,548 · 2022: $6,409 · 2023: $4,516 · 2024: $9,335 · 2025: $9,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19K · Food and Beverage: $5,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $18,541.66 |
| Food and Beverage | $5,177.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $24,030.73 | 2019-2025 | Penumbra System, Indigo System |
| Angiodynamics, INC. | $18,541.66 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Abiomed | $1,277.00 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $959.05 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Novartis Pharmaceuticals Corporation | $802.35 | 2019-2025 | |
| Amgen INC. | $738.94 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $710.27 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $564.51 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Shockwave Medical, INC | $550.51 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $519.35 | 2019-2022 | |
| Abbott Laboratories | $479.02 | 2019-2024 | Dragonfly Opstar, Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.50 | 2019-2025 | |
| Pfizer INC. | $393.23 | 2019-2025 | |
| Medtronic Vascular, INC. | $366.46 | 2019-2020 | |
| Medtronic, INC. | $287.58 | 2021-2024 | Endurant Iis, Onyx Frontier, Ffrangio |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $272.52 | 2022-2025 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $253.88 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $253.55 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $168.41 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $148.07 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $145.97 | 2019-2024 | Evkeeza |
| Merck Sharp & Dohme LLC | $144.65 | 2021-2025 | Verquvo, Capvaxive |
| Impulse Dynamics (USA) INC. | $144.51 | 2021-2023 | Optimizer |
| Asahi Intecc USA, INC. | $138.48 | 2020-2025 | Asahi Peripheral Vascular Wires |
| Philips North America LLC | $127.27 | 2023-2025 | Diagnostic Ecg Service, Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $113.71 | 2019-2025 | |
| Recor Medical INC | $110.80 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $105.93 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $97.90 | 2020-2021 | |
| Reflow Medical INC | $94.81 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $90.11 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $82.02 | 2024-2025 | |
| Astellas Pharma US INC | $77.24 | 2020-2021 | |
| Cardiva Medical, INC. | $76.47 | 2019-2025 | Optowire, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Esperion Therapeutics, INC. | $71.78 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $71.40 | 2021-2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $46.47 | 2023 | Definity |
| Bridgebio Pharma, INC. | $43.68 | 2025 | Attruby |
| Amryt Pharma Holdings LTD | $38.46 | 2021-2022 | |
| Edwards Lifesciences Corporation | $34.10 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $32.99 | 2023 | Assure Wcd |
| Ionis Pharmaceuticals, INC. | $32.75 | 2025 | Tryngolza |
| Glaxosmithkline, LLC. | $32.54 | 2025 | Shingrix, Arexvy |
| Daiichi Sankyo INC. | $28.95 | 2023 | Injectafer |
| Livanova USA, INC. | $28.04 | 2020-2021 | |
| Chiesi USA, INC. | $25.20 | 2023 | Kengreal, Cleviprex |
| Celonova Biosciences, INC. | $23.63 | 2020 | |
| Genzyme Corporation | $23.40 | 2023 | |
| Lilly USA, LLC | $21.66 | 2025 | Zepbound |
| Akcea Therapeutics, INC. | $19.55 | 2019 | |
| Medicomp INC | $19.50 | 2022 | |
| Heartflow, INC. | $18.46 | 2025 | |
| Bardy Diagnostics, INC. | $18.44 | 2020 | |
| Atricure, INC. | $15.30 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Kowa Pharmaceuticals America, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Melchior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.